000 | 01735 a2200517 4500 | ||
---|---|---|---|
005 | 20250513040933.0 | ||
264 | 0 | _c19950511 | |
008 | 199505s 0 0 eng d | ||
022 | _a0266-4348 | ||
024 | 7 |
_a10.1136/sti.70.6.389 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aArmstrong, D K | |
245 | 0 | 0 |
_aA randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminata. _h[electronic resource] |
260 |
_bGenitourinary medicine _cDec 1994 |
||
300 |
_a389-93 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnus Diseases _xtherapy |
650 | 0 | 4 |
_aCondylomata Acuminata _xtherapy |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGenital Diseases, Female _xtherapy |
650 | 0 | 4 |
_aGenital Diseases, Male _xtherapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPodophyllin _xtherapeutic use |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aMaw, R D | |
700 | 1 | _aDinsmore, W W | |
700 | 1 | _aMorrison, G D | |
700 | 1 | _aPattman, R S | |
700 | 1 | _aWatson, P G | |
700 | 1 | _aNathan, P M | |
700 | 1 | _aMoss, T | |
700 | 1 | _aNayagam, A | |
700 | 1 | _aWade, A | |
773 | 0 |
_tGenitourinary medicine _gvol. 70 _gno. 6 _gp. 389-93 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/sti.70.6.389 _zAvailable from publisher's website |
999 |
_c7705257 _d7705257 |